Kin Shing Holdings Limited (HKG:1630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0490
-0.0010 (-2.00%)
Aug 14, 2025, 2:49 PM HKT

Revance Therapeutics Revenue

In the fiscal year ending March 31, 2025, Kin Shing Holdings had annual revenue of 878.76M HKD, down -29.39%. Kin Shing Holdings had revenue of 446.67M in the half year ending March 31, 2025, with 56.96% growth.

Revenue
878.76M
Revenue Growth
-29.39%
P/S Ratio
0.09
Revenue / Employee
713.86K
Employees
1,231
Market Cap
75.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025878.76M-365.79M-29.39%
Mar 31, 20241.24B769.79M162.14%
Mar 31, 2023474.77M-126.10M-20.99%
Mar 31, 2022600.86M76.91M14.68%
Mar 31, 2021523.95M89.30M20.55%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition